| 摘要 |
The invention discloses the use of imidazol¢1,2-a!pyridine-3-acetamide derivatives to produce a drug for the treatment of Parkinson's disease, parkinsonian syndromes, other extrapyramidal syndromes such as those classified under the heading of "parkinsonism plus" (Steele-Richardson-Olszewski syndrome, cortical-basal ganglionic degeneration, multi-system atrophy, Wilson's disease, Hallervorden-Spatz disease, Huntington's disease, neuroacanthocytosis), obsessive-compulsive disorders and other obsessivecompulsive syndromes, frontal and subcortical dementias. |
